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Glucocorticoids inhi bit linear growth
Glucocorticoids, at therapeutically useful dos-
ages, can inhibit linear growth [1—51 and, at the cel-
lular level, can inhibit cell replication and DNA syn-
thesis [1—3]. The inhibition of linear growth is also
associated with some arrest in bone maturation; af-
ter removing a source of excess glucocorticoid,
there may be a growth spurt which lessens but does
not abolish the total effect [1—4, 6, 71. Glucocorti-
coids can also inhibit growth of rats [1, 2], an animal
which may serve as a useful model; caution, how-
ever, should be exercised in interpreting the data
from some studies in which dosages around 2 mg of
hydrocortisone per day were used [11. Such a dos-
age is equivalent to more than a gram of hydro-
cortisone per day in humans and may not always be
applicable to the more common situations of steroid
therapy in man. Lower dosages, however, of gluco-
corticoids in the rat are also inhibitory [1].
In considering the mechanisms of inhibition of
growth by glucocorticoids, it must be asked what
tissues are directly affected and what is the action of
the steroid. Because detailed knowledge is lacking
in both of these areas, these comments will present
the prevailing thought as to the various pathways by
which steroids may inhibit growth.
Effects of growth hormone, somatoinedin, and tissues
involved in growth
Glucocorticoids can inhibit growth hormone pro-
duction in adults [2, 3, 6, 8—10], and some data sug-
gest that this is the case in children. For example,
the growth hormone response to insulin-induced
hypoglycemia is impaired in children [9]. The mech-
anism of glucocorticoid inhibition of growth, how-
0085-2538/781001 4-0330$0 1.00
© 1978 by the International Society of Nephrology.
330
ever, appears to be distal to any effects that the
steroid has on growth hormone production since
growth hormone administration will not overcome
the steroid effect on growth [11].
Glucocorticoid effects might be mediated through
an inhibition of somatomedin production. At pres-
ent, there is no clear answer. Earlier studies with
the sulfation factor bioassay method yielded con-
flicting results [12—15]. More recent studies with
radioimmunoassay methods suggest that levels of
somatomedin C are actually elevated in Cushing's
syndrome [16] (see also Lewy and Van Wyk, this
issue).
Glucocorticoids may work by direct inhibitory
actions on target tissues involved in growth. These
steroids inhibit growth, i.e., net DNA and protein
synthesis, and other cell functions in many tissues
(for review, see Refs. 1, 17—20). It is important to
know whether direct inhibition on tissues such as
bone or cartilage cells could contribute to the gross
inhibition of growth. Steroids can inhibit the growth
of isolated bone cells [211.
In summary, the growth-retarding actions of the
glucocorticoids may be mediated by inhibition of
growth hormone and somatomedin or by a direct ef-
fect on cells of growing bone tissue, cartilage, or
both. In any case, an understanding at the biochem-
ical level of the mechanisms by which glucocorti-
coids can affect individual cells must be analyzed.
At this time, many possible mechanisms can be
invoked, because steroids exert effects on many
biochemical processes in cells.
Mechanisms of the effects on individual tissues:
Involi'einent of glucocorlicoid receptors
Many aspects of the mechanisms of action of
glucocorticoids on inhibiting the growth of individ-
ual cells or tissues are comparable to those by
which steroids induce enzymes [17—191. There is
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hormonal penetration into cells and reversible bind-
ing to specific receptors. The hormone-receptor
complex then binds to the nuclear chromatin and,
in many cases, the latter step results in increases in
specific mRNAs. These are then translated into
proteins that mediate the glucocorticoid responses.
Thus, these steroids may induce proteins that are
growth-inhibitory. Another possibility is that the
hormone-receptor complex interaction with the
chromatin also causes a direct inhibition of mRNA
synthesis that results in an inhibition of growth.
Evidence for the latter is that there is a strong
correlation between the steroid structural and con-
centration requirements for binding and for growth
inhibition [22]. Similarly, there is a good correla-
tion between loss of receptors and loss of the ability
of the tissue to respond [22].
Cellular sensitivity to the c,'rowth-mhil,itin' actions of
seroids
There is varied glucocorticoid sensitivity in dif-
ferent target tissues. For example, Loeb found, in
the rat, that tissues like liver, heart, muscle, and
kidney are relatively sensitive to the glucocorti-
colds, whereas certain other tissues, e.g.. gastric
and jejunal mucosa, spleen, brain, and testis, are
relatively resistant 11] In addition, the sensitivity of
a given cell type to glucocorticoid-mediated growth
inhibition can show considerable variation: 1) there
can be an absolute loss of sensitivity associated
with loss of the glucocorticoid receptor [22]; and 2)
there can be variations in cellular sensitivity that do
not involve loss of the receptor because the cells
still respond in other ways. For example, in some
cases, the growth of fibroblasts is stimulated,
whereas in others it is inhibited by glucocorticoids
[22, 23]. These steroids can have stimulatory or in-
hibitory actions on cloned lines of cells, and the di-
rection of the response depends on the experimental
conditions (Guenzi D, Johnson L, Baxter JD, un-
published observations). If this finding can he ex-
tended to other systems, this property has major
implications in terms of potentially influencing the
effects of these steroids on growth in man. If there
are factors that alter the direction of the growth re-
sponse to these steroids, therapeutic interventions
may he designed that would prevent the steroid
from being growth-inhibitory.
,Steroid inhibitors' actions distal to the receptor: Selective
influences on individual processes
Although the specific glucocorticoid receptor is
implicated in steroid-induced inhibition of cell func-
tion, steps distal to this are obscure. One attractive
theory has been that the glucocorticoids rapidly in-
hibit some key process, which in turn triggers a cas-
cade effect that is generally inhibitory to growth of
the cell [24]. It was earlier postulated, for example,
that the major effect of steroids was to decrease glu-
cose uptake by cells [24]. In thymocytes and other
tissues, glucocorticoids do inhibit glucose uptake,
and glucose deprivation results in decreased adeno-
sine triphosphate production and in cell lysis. In
other cell types, however, whose growth is inhib-
ited by glucocorticoids, the steroid has no effect on
glucose uptake [24]. Thus, the hypothesis that
glucocorticoid inhibition of growth is due to a de-
crease in glucose uptake is not generally applicable.
In fact, even though glucocorticoid actions on such
tissues as muscle, lymphoid cells, skin, adipose tis-
sue, and connective tissue (which may include bone
cells) generally are inhibitory in terms of protein,
fat, nucleic acid, and carbohydrate metabolism, this
is not always so [17—20]. For example, steroids
stimulate synthesis of many enzymes and proteins
in the liver but inhibit DNA synthesis [1, 181. Thus,
a function, such as DNA synthesis, that is crucial
for cellular or linear growth can be selectively inhib-
ited in the absence of a generally inhibitory gluco-
corticoid response. These observations suggest that
a number of processes affecting cell growth, trans-
port of substrate, nucleic acid metabolism, and pro-
tein synthesis are individually regulated in either a
positive (e.g., enzyme induction in liver [18] or en-
hancement of the growth-stimulatory effects of fi-
broblast growth factor [25, 26]) or negative way
(e.g., decreased glucose uptake in thymocytes [24]
or DNA synthesis in a number of tissues [1]). The
major process that is responsible for steroid-
mediated growth inhibition is not known.
Receptoractions on chromatin.' An hypothesis
Interaction of the hormone-receptor complex
with chromatin could either result in induction of a
protein(s) that inhibits another function important
for growth, or it could more directly inhibit a vital
function. Also, in spite of the thinking that steroids
always act on transcription, the receptor influence
could conceivably not involve transcription (for re-
view, see Reference 27). One reason to think that
inhibitory glucocorticoid actions involve stimula-
tion of synthesis of a function that is lethal is based
on data using inhibitors of macromolecular syn-
thesis. Thus, blocking RNA or protein synthesis
abolishes the inhibitory effect of glucocorticoids on
glucose uptake into thymocytes [24] or on alpha-
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aminoisobutyric acid (a nonmetabolizable amino
acid) into hepatoma cells [281. A second reason to
think that glucocorticoids may induce an inhibitory
function is based on the view that steroids are
known to act by stimulating transcription. Indeed,
glucocorticoid-mediated increases in the rate of
synthesis of RNA can be observed within a few
minutes [29]. Further, there can be rapid receptor-
mediated changes in chromatin structure measured
by increases in the ability of bacterial RNA po-
lymerase to transcribe on isolated chromatin [30].
We have examined the early effects of steroids on
chromatin isolated from cultured fibroblasts and
lymphoid cells whose growth is affected by the
steroid (Johnson LK, Guenzi D, and Baxter JD, un-
published observations). After exposing these cells
to dexamethasone for 1 or 2 hr, before any gross
effects on cellular function can be observed, there
was a major decrease, instead of an increase, in the
ability of isolated chromatin to synthesize RNA af-
ter adding the bacterial RNA polymerase. From
these data, we hypothesize that the glucocorticoids
may inhibit cellular function by a very early modifi-
cation of chromatin structure. This modification can
be detected by a decrease in the capacity of
chromatin to synthesize RNA when bacterial poly-
merase is added. Since the receptors appear to af-
fect chromatin in many places, we speculate that in
most of the places where the receptor has an effect,
cellular function is not affected. Some of the modifi-
cations, however, do result in inhibiting synthesis
of RNA by chromatin. Much work needs to be done
to test this hypothesis. These studies provide an
indication that glucocorticoid-mediated inhibitory
effects on chromatin can be rapid. More recently,
we have found that the steroid can elicit stimula-
tory or inhibitory actions on the same cell type.
This provides a model system for manipulating the
cellular environment and cellular sensitivity to
glucocorticoids. Conceivably similar manipulations
in vivo could some day be used to minimize the ad-
verse affects of glucocorticoids on cellular growth.
Summary
Mechanisms whereby giucocorticoids might in-
hibit growth are reviewed from the perspective of
glucocorticoid effects on cell metabolism and
growth. Although glucocorticoids given to patients
decrease levels of growth hormone and possible
somatomedins, the effect of glucocorticoids on
growth is not reversed when growth hormone is giv-
en. Glucocorticoids inhibit cell growth in culture.
Cell inhibition correlates with binding of steroids to
the glucocorticoid receptors. Some tissues are very
sensitive; others are insensitive. In cell culture,
changes in sensitivity can be associated with
changes in binding, but this is not always the case in
tissues of the animal. The mechanisms of inhibition
of cell growth are not known. It could be due to
steroid-induced synthesis of inhibitory proteins or
to blocking by receptor-steroid complexes of the
synthesis of RNA. Steroids may affect uptake of
substrates, e.g., glucose or amino acids, which in
turn affects growth. The inhibitory actions of gluco-
corticoids on individual tissues may explain why
these steroids inhibit growth in the animal. It is not
known, however, how the steroid inhibits linear
growth in mass or which cell types are most impor-
tant targets for such effects.
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